Chuanzhi Duan
Southern Medical University, China · Zhujiang Hospital · Department of Neurosurgery, Zhujiang Hospital,Southern Medical University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Chuanzhi Duan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:10 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07353749 · Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial AneurysmsDuan Chuanzhi · not yet recruiting · Unruptured Intracranial Aneurysms, Cerebrovascular Event, Hemorrhagic Stroke · study director
- N/ANCT07353736 · Cerebral Arteriovenous Malformation With Aneurysm: Epidemiology, Clinical Features, and PrognosisDuan Chuanzhi · not yet recruiting · Cerebral Arteriovenous Malformation, Intracranial Arterial Diseases, Intra Cerebral Hemorrhage · principal investigator
- Ph2NCT06712004 · A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic StrokeZhujiang Hospital · recruiting · Ischemic Stroke, Acute, Ischemic Stroke, Cerebral Infarction · study director
- N/ANCT06446778 · Pipeline Embolization for Intracranial AneurysmsZhujiang Hospital · recruiting · Efficacy, Self, Hemodynamic Instability, Stenosis · study director
- Ph4NCT06308952 · Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter ImplantationDuan Chuanzhi · recruiting · Cerebrovascular Event, Stent Stenosis, Ischemic Stroke · study director
- N/ANCT05755516 · Efficacy and Safety of the Self-expanding Intracranial Stent (Tonbridge) for Endovascular Treatment of Intracranial AneurysmsTon-Bridge Medical Tech. Co., Ltd · completed · Intracranial Aneurysm · principal investigator
- N/ANCT04289480 · Safety and Effectiveness of ENTERPRISE 2 Device in the Endovascular Treatment of Intracranial AneurysmsMedos International SARL · completed · Intracranial Aneurysm · principal investigator
- N/ANCT03387995 · Safety and Efficacy of Stent Deployment for Intracranial Aneurysms (SESIA)Zhujiang Hospital · completed · Treatment Outcome by Stent-assisted Embolization · principal investigator
- N/ANCT03133598 · Treatment of Unruptured Intracranial Aneurysms in ChinaZhujiang Hospital · completed · Intracranial Aneurysm, Stent Embolisation, Craniotomy · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:10 UTC. The ranking covers the 200 most relevant of 70 PubMed records, and a shared surname and initials can bring in a namesake. All 70 on PubMed
- Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC.J Thorac Oncol · 2020356 citationsRCR 12.7
- Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.J Clin Oncol · 2009255 citationsRCR 5.9
- 212 citationsRCR 10.2
- Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy.N Engl J Med · 2024197 citationsRCR 35.7
- Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier.PLoS One · 2016178 citationsRCR 6.7
- Neutrophil-to-Lymphocyte Ratio Positively Correlates to Age in Healthy Population.J Clin Lab Anal · 2015142 citationsRCR 5.4
- 96 citationsRCR 10.0
- Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study.J Clin Oncol · 202365 citationsRCR 4.7
- Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial.JAMA Intern Med · 202164 citationsRCR 3.4
- 62 citationsRCR 3.5